Athenex Inc (ATNX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1001 MAIN STREET BUFFALO, NY 14203

Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery, development, and commercialization of next generation drugs for the treatment of cancer. Athenex is organized around three platforms, including an Oncology Innovation Platform, a Commercial Platform, and a Global Supply Chain Platform. The Company's current clinical pipeline is derived from four different platform technologies: (1) Orascovery, based on P-glycoprotein inhibitor, (2) Src kinase inhibition, (3) T-cell receptor-engineered T-cells (TCR-T), and (4) Arginine deprivation therapy. Athenex's employees worldwide are dedicated to improving the lives of cancer patients by creating more active and tolerable treatments. Athenex has offices in Buffalo and Clarence, New York; Cranford, New Jersey; Houston, Texas; Chicago, Illinois; Hong Kong; Taipei, Taiwan; multiple locations in Chongqing, China; Manchester, UK; Guatemala City, Guatemala and Buenos Aires, Argentina.

Data as of 2021-06-19 12:34:46 -0400
Market Cap439.51 Million Shares Outstanding93.513 Million Avg 30-day Volume1.516 Million
P/E Ratio-2.89532 Dividend Yield EPS-1.72
Price/Sales3.17 Debt to Equity2.21 EBITDA-124.036 Million
Price to Book Value2.78 Forward PE-4.04 Enterprise Value417.579 Million
Total Cash171.166 Million Current Debt49.703 Million Gross Profit46.293 Million
BETA0.52482 52-week High/Low15.24 / 3.66 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ATNX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 121 131 -7.63% 41 (2.41%) 45 (2.61%) -8.89%
13F shares: 53.45 Million 49.985 Million 6.93% 24.521 Million 29.495 Million -16.87%
% Ownership 57.1933 53.5522 6.8% 26.238 31.6001 -16.97%
New Positions: 22 23 -4.35% 12 12 0.0%
Increased Positions 43 52 -17.31% 13 15 -13.33%
Closed Positions 31 25 24.0% 16 15 6.67%
Reduced Positions 39 36 8.33% 12 14 -14.29%
Total Calls 531.39 Thousand 238.722 Thousand 122.6% 110.2 Thousand 42.4 Thousand 159.91%
Total Puts 1.059 Million 328.846 Thousand 222.06% 216.2 Thousand 105.7 Thousand 104.54%
PUT/CALL Ratio 1.99 1.38 44.2% 1.96 2.49 -21.29%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ATNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

8.7 Thousand total shares from 4 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

104 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LAU JOHNSON YIU NAM CEO AND CHAIRMAN OF THE BOARD

  • Officer
  • Director
7,933,895 2021-05-07 18

KWAN RUDOLF EVP, CHIEF MEDICAL OFFICER

  • Officer
1,223,768 2021-05-07 2

CAMPBELL KIM

  • Director
121,000 2021-05-06 2

VIERLING JOHN

  • Director
28,750 2021-05-06 1

WU JINN

  • Director
918,916 2021-05-05 4

ZUO WILLIAM WEI PRESIDENT, CHINA DIVISION

  • Officer
287,884 2021-03-04 1

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
13,532,467 2020-09-14 1

FOK MANSON

  • Director
2,785,670 2020-09-11 1

YORDON JEFFREY SEE REMARKS

  • Officer
237,106 2020-09-10 1

SZE RANDOLL CHIEF FINANCIAL OFFICER

  • Officer
6,000 2020-09-10 1

DAVIS STEPHANIE A

  • Director
20,000 2020-09-10 2

KANFER JORDAN

  • Director
4,634 2020-09-10 1

BAIR TERESA BROPHY GENERAL COUNSEL, SVP ADMIN.

  • Officer
0 2020-08-27 2

SPIEGEL ROBERT J.

  • Director
0 2020-08-05 2

PEDDER SIMON SEE REMARKS

  • Officer
5,310 2020-06-05 0

TSANG BENSON KWAN HUNG

  • Director
10,000 2020-06-05 0

KOH JOHN

  • Director
0 2020-06-05 0

TRAINOR-DEGIROLAMO SHELDON

  • Director
611,333 2019-03-14 0

ZHANG SONG-YI

  • Director
5,197,668 2019-03-11 0

ZHANG SONG-YI

MANDRA MEDICAL LTD

BEANSPROUTS LTD

MUI BING HOW TAMMY

  • Director
  • 10% Owner
6,422,189 2018-08-23 0

SHEN LI SEE REMARKS.

  • Officer
200 2018-01-01 0

LEUNG ANTONY

2,103,028 2017-06-19 0

CANNON MICHAEL D

0 2017-06-19 0

RIEHLE J NICK CHIEF FINANCIAL OFFICER

1,500 2017-06-19 0

ZUKIN JAMES

0 2017-06-19 0

MA HUATENG

ADVANCE DATA SERVICES LTD

  • 10% Owner
6,444,032 2017-06-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LAU JOHNSON YIU NAM - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2021-05-07 16:46:37 -0400 2021-05-07 M 5,000 d 75,000 direct

KWAN RUDOLF - Officer EVP, CHIEF MEDICAL OFFICER

2021-05-07 16:58:57 -0400 2021-05-07 M 24,000 d 24,000 direct

LAU JOHNSON YIU NAM - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2021-05-07 16:46:37 -0400 2021-05-07 M 5,000 $4.55 a 3,247,959 direct 7.4114 -0.6445 9.13 5 -0.6445 6

VIERLING JOHN - Director

2021-05-10 16:19:54 -0400 2021-05-07 P 250 $4.50 a 3,750 direct -5.6 -6.4 1.6 4 -7.5 5

KWAN RUDOLF - Officer EVP, CHIEF MEDICAL OFFICER

2021-05-07 16:58:57 -0400 2021-05-07 M 24,000 $4.55 a 167,768 direct 7.4114 -0.6445 9.13 5 -0.6445 6

CAMPBELL KIM - Director

2021-05-07 16:13:48 -0400 2021-05-06 P 1,750 $4.03 a 10,000 direct 7.4114 -0.6445 9.13 5 -0.6445 6

VIERLING JOHN - Director

2021-05-10 16:19:54 -0400 2021-05-06 P 1,700 $4.04 a 3,500 direct -5.6 -6.4 1.6 4 -7.5 5

LAU JOHNSON YIU NAM - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2021-05-06 19:12:53 -0400 2021-05-06 P 5,000 $3.99 a 3,242,959 direct 1.1957 10.4348 10.4348 6 0.0 1

LAU JOHNSON YIU NAM - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2021-05-05 17:24:44 -0400 2021-05-05 M 25,000 $4.55 a 3,237,959 direct 7.4766 14.9533 9.8131 19.8598 27 0.0 1

WU JINN - Director

2021-05-05 17:33:43 -0400 2021-05-05 M 10,000 d 0 direct

WU JINN - Director

2021-05-05 17:33:43 -0400 2021-05-05 M 10,000 $4.55 a 353,208 direct 7.4766 14.9533 9.8131 19.8598 27 0.0 1

WU JINN - Director

2021-05-05 17:33:43 -0400 2021-05-05 M 40,000 d 0 direct

LAU JOHNSON YIU NAM - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2021-05-05 17:24:44 -0400 2021-05-05 M 25,000 d 80,000 direct

WU JINN - Director

2021-05-05 17:33:43 -0400 2021-05-05 M 40,000 $4.55 a 343,208 direct 7.4766 14.9533 9.8131 19.8598 27 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ATHENEX INC ATNX 2021-06-18 22:15:03 UTC -0.6624 0.7424 1100000
ATHENEX INC ATNX 2021-06-18 21:45:03 UTC -0.6624 0.7424 1100000
ATHENEX INC ATNX 2021-06-18 21:15:03 UTC -0.6624 0.7424 1100000
ATHENEX INC ATNX 2021-06-18 20:45:03 UTC -0.6634 0.7434 1100000
ATHENEX INC ATNX 2021-06-18 20:15:04 UTC -0.6634 0.7434 1100000
ATHENEX INC ATNX 2021-06-18 19:45:03 UTC -0.6634 0.7434 1100000
ATHENEX INC ATNX 2021-06-18 19:15:03 UTC -0.6634 0.7434 1100000
ATHENEX INC ATNX 2021-06-18 18:45:03 UTC -0.6634 0.7434 1400000
ATHENEX INC ATNX 2021-06-18 18:15:02 UTC -0.6634 0.7434 1400000
ATHENEX INC ATNX 2021-06-18 17:45:03 UTC -0.6669 0.7069 1400000
ATHENEX INC ATNX 2021-06-18 17:15:03 UTC -0.6669 0.7069 1400000
ATHENEX INC ATNX 2021-06-18 16:45:03 UTC -0.6669 0.7069 1400000
ATHENEX INC ATNX 2021-06-18 16:15:03 UTC -0.6669 0.7069 1400000
ATHENEX INC ATNX 2021-06-18 15:45:03 UTC -0.6669 0.7069 1400000
ATHENEX INC ATNX 2021-06-18 15:15:03 UTC -0.6669 0.7069 1400000
ATHENEX INC ATNX 2021-06-18 14:45:03 UTC -0.6669 0.7069 1400000
ATHENEX INC ATNX 2021-06-18 14:15:03 UTC -0.6669 0.7069 1400000
ATHENEX INC ATNX 2021-06-18 13:45:03 UTC -0.6669 0.7069 1400000
ATHENEX INC ATNX 2021-06-18 13:15:03 UTC -0.6669 0.7069 1400000
ATHENEX INC ATNX 2021-06-18 12:45:03 UTC -0.6669 0.7069 1400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments